Background and Purpose-Early assessment of the likelihood of neurological recovery in comatose cardiac arrest survivors remains challenging. We hypothesize that quantitative noncontrast computed tomography (NCCT) combined with neurological assessments, are predictive of outcome. Methods-We analyzed data sets acquired from comatose cardiac arrest patients who underwent CT within 72 hours of arrest. Images were semiautomatically segmented into anatomic regions. Median Hounsfield units (HU) were measured regionally and in the whole brain (WB). Outcome was based on the 6-month modified Rankin Scale (mRS) score. Logistic regression was used to combine Glasgow Coma Scale (GCS) score measured on Day 3 post arrest (GCS_Day3) with imaging to predict poor outcome (mRSϾ4). Results-WB HU (Pϭ0.02) and the ratio of HU in the putamen to the posterior limb of the internal capsule (PLIC) (Pϭ0.004) from 175 datasets from 151 patients were univariate predictors of poor outcome. Thirty-three patients underwent hypothermia treatment. Multivariate analysis showed that combining median HU in the putamen (Pϭ0.0006) and PLIC (Pϭ0.007) was predictive of poor outcome. Combining WB HU and GCS_Day3 resulted in 72% [61% to 80%] sensitivity and 100% [73% to 100%] specificity for predicting poor outcome in 86 patients with measurable GCS_Day3. This was an improvement over prognostic performance based on GCS_Day3Յ8 (98% sensitive but 71% specific). Discussion-Combining density changes on CT with GCS_Day3 may be useful for predicting poor outcome in comatose cardiac arrest patients who are neither rapidly improving nor deteriorating. Improved prognostication with CT compared with neurological assessments can be achieved in patients treated with hypothermia. (Stroke. 2011;42:00-00.)
A ccurate prediction of neurological recovery after cardiac arrest remains problematic. Prognostic techniques have traditionally relied on clinical examinations, electrophysiological measurements or biochemical changes. 1, 2 However, these are most effective only for patients either rapidly recovering who will have a good outcome, or for those severely injured who will have a poor outcome. Although some suggest that a Glasgow Coma Scale (GCS) score Ͻ5 within the first 48 hours is predictive of poor outcome, 3, 4 others have demonstrated that GCS at admission was a poor predictor. 5 At 72 hours, GCS Ͻ6 was 67% sensitive at 85% specificity 6 for predicting poor prognosis. The evidencebased review of the American Academy of Neurology Practice Parameters (AANPP) reported that clinical findings associated with poor outcome 3 days after resuscitation were absent pupillary light response (PLR) or corneal reflexes (CR), or extensor posturing, or no motor response to pain. 7 The guidelines concluded there was insufficient evidence to support or refute the use of brain imaging for prognostication.
Diffusion-weighted imaging is sensitive to brain injury after transient global ischemia. Two large independent studies showed that severe reductions in the apparent diffusion coefficient (ADC), a measurement of tissue water diffusivity sensitive to cytotoxic edema, are linked to poor long-term outcome. 8, 9 Although these magnetic resonance imaging (MRI) findings are extremely promising, MRI can be difficult to acquire in critically ill patients because of necessary monitoring and treatments. 10, 11 This has led some to suggest using changes in noncontrast computed tomography (NCCT) for prognostication. 12 Studies showed that patients with good neurological recovery had a higher gray-matter-to-whitematter Hounsfield units (HU) ratio than did those who did poorly [13] [14] [15] ; however, these studies had relatively small sample sizes.
Our goals were to determine whether early changes in NCCT predict poor functional recovery in comatose post cardiac arrest patients in a large patient cohort, examine spatio-temporal patterns in the evolution of brain injury and recovery, and determine whether imaging combined with clinical findings provides better prediction of poor clinical outcome versus using clinical findings alone.
Methods Patients
An Institutional Review Board-approved single-center prospective observational study of 500 patients with nontraumatic coma was performed from 2000 to 2007. Critically ill patients admitted to intensive care units who had an admission diagnosis of coma, or had an ensuing diagnosis of coma during admission were eligible for inclusion. To meet the definition of coma by Levy et al, 16 patients failed to open their eyes either spontaneously or in response to noise, expressed no comprehensible words, and neither obeyed commands nor moved extremities appropriately to localize or resist painful stimuli. Patients were excluded who were found to have a traumatic cause for coma. We excluded patients younger than 18 years of age, as younger age groups may have different outcomes. Patients who were kept in a pharmacological coma (eg, postoperatively), or who were found to be in a comatose state on discontinuation of medications were also excluded on the basis that there would be no method for dating inception of the comatose state; therefore, daily clinical data would be of unclear benefit. Within this cohort, 200 patients were comatose secondary to hypoxic-ischemic brain injury. The decision to acquire additional testing, including neuroimaging, was at the discretion of the treating clinicians. Patients underwent routine clinical evaluations, including detailed neurological assessments, on days 0, 1, 3, and 7, and a modified Rankin Scale (mRS) score was obtained at 3 months and 6 months in surviving patients. Neurological assessments included GCS, PLR, CR and GCS motor score (M). Of the 200 patients, 166 underwent computed tomography (CT) imaging within 7 days of arrest. Patients were excluded if hemorrhage or a previous stroke was noted, if imaging was of poor quality, or if the first imaging study was performed Ͼ72 hours from arrest. This resulted in 151 patients. Some patients underwent repeat imaging, resulting in a total of 175 imaging studies performed within 3 days of arrest.
Imaging Studies
Because of the observational nature of the study, the imaging parameters of the 175 studies varied, consisting of 5 mm (Nϭ169), 3 mm (Nϭ5) and 2 mm (Nϭ1) thick slices with median [ 18 Using the ICBM probabilistic atlases, 19,20 masks were generated for the following regions: cerebellum, frontal lobe (FL), insula, occipital lobe (OL), parietal lobe (PL) and temporal lobe (TL), caudate nucleus (CN), putamen, thalamus and white matter (WM). Further segmentation of WM regions into the posterior limb of the internal capsule (PLIC), corpus callosum (CC) and corona radiata (CorRad) was performed using the Johns Hopkins University (JHU) ICBM-DTI-81 WM atlas 21, 22 distributed as part of the Functional MRI of the Brain Software Library. 23 Only tissue with Ͼ50% probability was included for analysis (see Figure 1 ). Median Hounsfield units (HU) were measured in each region and the whole brain (WB). To exclude cerebral spinal fluid and artifacts, analysis was limited to HU between 15 and 100.
Statistical Analysis
Spatial differences among the regions were examined using a one-way analysis of variance with post hoc Student-Newman Keuls test. Clinical outcome was defined by modified Rankin Scale (mRS) as either good outcome (mRSՅ4) or bad outcome (mRSϾ4). Differences in patients with good outcome were compared (twotailed Wilcoxon rank-sum test) with patients with poor outcome. We also compared differences in demographics (two-tailed Wilcoxon rank-sum test) between patients who were included in this study and the patients in the database who were excluded. For categorical variables, a 2-sided Fisher's Exact test was used. Since the AANPP predictions require a neurological examination to be performed on Day 3, we performed subset analysis between patients for whom GCS could be measured on Day 3 (Group I) and patients for whom GCS could not be obtained (because of death or "comfort measures only" status) on Day 3 (Group II). Subset analysis examining differences between early and late imaging was performed for patients imaged within 24 hours and beyond 24 hours. Logistic regression was performed using the bias-reduction method 24, 25 to investigate the relationship between poor or good outcome and GCS at baseline (GCS_Day0) (acquired at admission or Day 1), GCS_Day3, age, sex, time-to-CT (days from last seen well), whether the patient had a shockable rhythm, whether the patient was treated with hypothermia and WB HU. We also investigated the prognostic performance of poor recovery using AANPP, 7 in which poor outcome was classified by absence of CR, PLR, or M2. For multivariate analysis, the decision regarding which parameters to include in a forward stepwise method was based on the Akaike Information Criterion, a measure that is a function of both training error and complexity. 26 Multivariate analysis was performed to evaluate the contribution of anatomic regions for prediction of outcome. Sensitivity and specificity estimates were calculated using jack-knifing or leave-one-out approach 27 for which the model coefficients for a particular imaging dataset were calculated using all other datasets in order to avoid evaluating the model performance on the same data on which it was trained. Sensitivities were calculated for the case of minimum false-positives, and maximum number of true positives. 95% CI was calculated according to the efficient-score method. 28, 29 The sensitivities of different models at the same specificity were compared using a McNemar test. 30 Figure 1 . A, Probabilistic atlas: different color codes represent the probability of tissue found at a position to belong to various tissue regions (ie, CN, putamen, thalamus, cerebellum, FL, insula, OL, PL, TL, WM, PLIC, CC, and CorRad), shown in axial, sagittal and coronal views. For clarity, only tissue with probability Ͼ50% of classification is shown. Also shown, using the same dynamic range, are coregistered NCCT from (B) a 66-year-old woman who had a 6-month mRSϭ6 (died) and (C) a 41-year-old woman who had a 6-month mRSϭ1 (good outcome).
Logistic regression analysis was repeated excluding hypothermiatreated patients to evaluate the influence of hypothermia on patient prognostication. Hypothermia was adopted at our institution in 2002. The reasons some of our patients did not undergo hypothermia included being outside of the time window and being too unstable from a cardiovascular standpoint. Table 1 shows demographics of the 151 patients with usable imaging performed within 72 hours of arrest, dichotomized by good or poor neurological outcome at 6 months. There was no significant statistical difference (PϾ0.05) between included patients and those who were excluded for not having usable CT scans (Nϭ49) age (61.5Ϯ16.3 years), female sex (37%), shockable rhythm (35%), treatment with hypothermia (12%), GCS_Day3 (3 [range 3-15]), absent PLR (22%), absent CR (22%), MՅ2 (72%) and 6-month mRS (6 [range 0 -6]). Patients who did not undergo imaging had significantly lower (Pϭ0.02) GCS_Day0 scores (3 [range [3] [4] [5] [6] [7] ) and a significantly lower (Pϭ0.02) proportion of patients for whom GCS_Day3 could be measured (37%). For the included patients, there was a significantly higher proportion of cases with shockable rhythms in the good versus poor outcome group. There was a significant difference in the percentage of patients treated with hypothermia in the good outcome group. GCS_Day0 was measured on Day 0 for 125 patients, and on Day 1 for 26 patients. There was no significant difference in GCS_Day0 between outcome groups, but, for the subset of patients (Nϭ86) who had GCS_Day3 measured (Group I), there was a significant difference in GCS_Day3 between good and poor outcome groups. For Group I, there was still no statistically significant difference (PϾ0.05) in GCS_Day0 between poor and good outcome groups. There was also a significant difference in the distribution of patients on Day 
Results

Patient Demographics
Regional Analysis
CC and CorRad exhibited significantly lower median HU (PϽ0.001) while TL and OL exhibited significantly higher median HU (PϽ0.01) than did the other regions. A significant difference (PϽ0.05) was found between all regions except the insula for patients with good versus poor outcome ( Table 2 ). The ratio of putamen/PLIC was significantly different between the 2 outcome groups. No statistically significant difference was found between Group I (Nϭ102) and Group II (Nϭ73) for whole brain HU (Pϭ0.09), and WM (Pϭ0.07), CC (Pϭ0.21), CorRad (Pϭ0.25), FL (Pϭ0.23), insula (Pϭ0.07) and CN (Pϭ0.10), but differences were found for the other regions (PϽ0.05).
Temporal Analysis
One-hundred nineteen NCCT scans were performed within 24 hours of arrest (early), and 42 scans were performed between 24 to 72 hours after arrest (late). The time of arrest could not be determined well enough in 14 scans to determine whether the patient was scanned within 24 hours. Regionally, only the putamen showed significant (Pϭ0.03) reductions in the late group (29.5 [27.7-31.9 ]) compared with the early group (31.0 [29.0 -33.0]). For all other regions, no difference was found. For Group I, 59% of the studies were performed within 24 hours, 15% between 1 and 2 days, 15% between 2 and 3 days. For Group II, 81% were performed within 24 hours, 12% between 1 and 2 days, and 4% between 2 and 3 days. Time from the event could not be determined accurately for the remaining datasets. For the early cohort, there was a significant difference in median HU between outcome groups for WB, WM and all regions except the insula, and PL (Table  3 ). In contrast, in the late cohort, for which there were only 3 scans associated with good outcome, no significant difference was found between outcome groups. However, a significant difference was found between putamen/PLIC for the 2 groups.
Logistic Regression
Of age, sex, GCS_Day0, time-to-CT, presence of shockable rhythm, hypothermia treatment, and WB, WB (Pϭ0.02), lack of hypothermia treatment (Pϭ0.003), and nonshockable rhythm (Pϭ0.01) were significant univariate predictors of Table  4 and Figure 2 . Our sensitivity and specificity results on Day 3 using a GCS cutoff of 6 and PLR are similar to those described in the AANPP. 7 No threshold of GCS_Day3 was 100% specific for predicting poor outcome in all patients. Sensitivity of absent CR is greater than that reported in the AAN Practice Paramers guidelines. 7 However, we did not obtain a 0% false-positive rate for MՅ2. Excluding 29 datasets from 23 patients treated with hypothermia resulted in no false-positives for MՅ2 criterion and, by extension, the AANPP (Table 4) in the 73 remaining datasets. Excluding hypothermia-treated patients also dramatically increased the prognostic performance of GCS_Day3% to 100% sensitivity at 100% specificity when using a cutoff of 8.
The ratio of putamen/PLIC was a significant univariate predictor (Pϭ0.004), while the ratio of CN/PLIC was not (Pϭ0.56). Using Akaike Information Criterion for selecting which tissue regions to include in a multivariate model, the optimal model included the putamen (Pϭ0.0006) and PLIC (Pϭ0.007). Combining GCS_Day3 with WB, putamen and PLIC or putamen/PLIC increased sensitivity. Adding WB to MՅ2, or AANPP improved the performance of MՅ2 prediction for specificity equaling 100%, and by extension AANPP, but not PLR absence or CR absence. Based on the minimum Akaike Information Criterion, when including GCS_Day3 and different brain regions, the optimal model included GCS_ Day3 (Pϭ0.0002), cerebellum (Pϭ0.02), insula (Pϭ0.09), FL (Pϭ0.06) and WB (Pϭ0.12), resulting in significantly higher WBϩCR absent 50 ͓39-61͔ 100 ͓73-100͔ 60 ͓47-71͔ 100 ͓52-100͔
Putamen/PLICϩGCS_Day3 10 ͓5-19͔ 100 ͓73-100͔ 100 ͓93-100͔ 100 ͓52-100͔
Putamen/PLICϩPLR 24 ͓16-34͔ 100 ͓73-100͔ 27 ͓17-39͔ 100 ͓52-100͔
Putamen/PLICϩCR 50 ͓39-61͔ 100 ͓73-100͔ 57 ͓44-69͔ 100 ͓52-100͔
The number of data sets from patients with good outcome (mRSՅ4) and total data sets are provided in parenthesis as well as percentage.
sensitivity (PϽ0.001), and predicted poor outcome while maintaining the same specificity as GCS_Day3ϩWB model (Table 4) . When excluding hypothermia-treated patients, the optimal model consisted of GCS_Day3 (Pϭ0.01), resulting in 100% sensitivity at 100% specificity; however, this model does not reach 100% specificity when including all patients.
Discussion
Our results show that neuroimaging combined with the neurological examination can improve prediction of clinical outcome for patients who survive more than 24 hours after cardiac arrest. Consistent with MRI studies that showed that global ADC reductions are predictive of poor outcome, 8, 9 our study shows that changes in the brain caused by cytotoxic edema resulting in decreases in median WB HU are also predictive. Not surprisingly, the initial rhythm of cardiac arrest (ie, whether it was shockable or not) and GCS_Day3 were also found to be significant predictors.
Torbey et al showed that combining neuroimaging (ratio of CN/PLIC) with clinical parameters (reversed GCS and duration of arrest) can improve patient prognostication 31 in a cohort of 32 patients. Our study did not include duration of arrest because it could not be determined accurately in the majority of our patients because it was not prospectively recorded. Our study also included only patients with a maximum admission GCS of 8, while the Torbey et al study included patients with GCS scores up to 15; this suggests that our patients consisted of a more critically ill population. In addition, the CN HU in our study (27 [25-29] ) was lower than that reported in previous studies, 13, 14 again indicative of a more severely brain injured group. Our study strictly included only truly comatose patients, which may help to explain the high mortality rate in contrast with other studies that may have included post-cardiac arrest patients who had a depressed level of consciousness but who were not comatose. This led to the limited number of patients with good outcomes, which in turn resulted in the large CIs in our specificity for predicting poor outcome. Additional studies are therefore necessary, involving greater number of patients to more accurately estimate the specificity of tools for prognosticating poor outcome in comatose cardiac arrest patients before such tools can be used for clinical decisionmaking. These studies should be limited to those patients in whom the prognosis is truly in question, excluding those rapidly awakening (and therefore have higher GCS scores) or brain dead.
Regionally, we found that decreased HU in the putamen and the PLIC were significant predictors of poor outcome, not surprising given their important roles in motor function and the emphasis of mRS on motor recovery. 32 In addition, the early selective sensitivity of the basal ganglia to global ischemia has been well documented. 12 We found that the ratio of the putamen/PLIC but not CN/PLIC was predictive of poor outcome, consistent with a previous study by Torbey et al. 13 Another study 14 by Choi et al found that CN/PLIC within 24 hours in 28 patients was predictive of poor outcome. Differences in our findings are likely because of differences in outcome measures, patient cohorts and timing of CT. Subset analysis of patients imaged early or late showed that putamen/PLIC was significantly associated with poor recovery only for patients scanned Ͼ24 hours post-cardiac arrest. In comparison, the other regions no longer exhibited significant differences in the late group, despite being significantly different within 24 hours (Table 3) ; this is likely because of limited number of patients with good recovery (Nϭ3) in the late group. Of all the regions examined, only the putamen demonstrated a significant decline between early and late CT HU values.
Our regional results are consistent with our MRI study in comatose postcardiac arrest patients. 8 In the MRI study, for 48 patients imaged within 72 hours, ADC values tended to be higher in the patients who achieved good outcomes (Nϭ6) compared with those with poor outcomes (Nϭ42). These differences were not statistically significant for all regions, likely because of the limited sample size, which then resulted in the MRI study being underpowered for regions that did not demonstrate severe ADC reduction. Further, there are temporal differences in the 2 studies. In the MRI study, 21% of the studies were performed on Day 0, while for this CT study 68% were performed on Day 0. We speculate that pseudonormalization in ADC as a result of reperfusion, as demonstrated in animal models of global ischemia, 33 may diminish detectable differences in ADC values between patients with good and poor outcomes the later the MRI is obtained. To properly compare the strengths and weaknesses of the 2 imaging modalities, and to understand the physiological implications of differences in findings, one would need a prospective study in which both modalities were acquired at similar time points.
For patients for whom Day 3 neurological examination data were collected, our sensitivity and specificity results for the predictive performance of clinical signs for poor outcome Figure 2 . Receiver operator characteristic curves for prediction of poor outcome using WB, putamen and PLIC, as well as putamen/PLIC individually and in combination with GCS_Day3. Also shown is the receiver operator characteristic curve for the model consisting of WB, FL, cerebellum, insula and GCS_Day3, which outperformed the other models at 100% specificity.
were consistent with previously published findings. 7 Discrepancies in predictive performance when using either MՅ2 or AAN Practice Parameters recommendations were found for patients who underwent hypothermia therapy, suggesting caution is needed when using motor response for prognostication purposes given that hypothermia-treated patients may have poor motor responses on Day 3 despite eventual good outcome. 2, 34 For patients for whom GCS_Day3 was obtained, combining neuroimaging data with neurological examination data improved prognostication of patient outcome over use of imaging or clinical data alone. For patients in whom prognostication is most difficult, ie, those who are not rapidly deteriorating, imaging may therefore provide supplemental information regarding the severity of brain injury. Although sophisticated brain segmentation techniques can significantly increase prognostic performance of our models, inclusion of a single easily measured parameter, ie, median WB HU, was able to offer significant improvements over the sole use of GCS measured 3-days post-cardiac arrest. Multivariate models involving regional changes, however, may be useful for providing insight into the pathophysiological processes following global hypoperfusion and resuscitation. Exclusion of hypothermia patients also improved prognostication for the multivariate models, although using GCS3Յ8 provided 100% sensitivity at 100% specificity. This suggests that patients not treated with hypothermia who are still comatose on Day 3 will likely have a poor outcome. For patients treated with hypothermia, this may be inaccurate. In addition, not all hypothermia-treated patients had a good outcome. Of the 33 patients who received hypothermia treatment, 79% had a poor outcome. The percentage of patients with good outcomes (21%) is much lower than what has previously been reported in 2 randomized studies of hypothermia treatment in survivors of cardiac arrest caused by ventricular fibrillation, in which 43% to 55% of the patients treated had good outcomes. 35, 36 We suspect this may be due to the fact that only 55% (Nϭ18) of our treated patients had shockable rhythms, and of these only 33% (Nϭ6) had good outcomes. The addition of imaging increased the specificity of neurological exams and maintained high specificity even for patients treated with hypothermia. This is especially important, as hypothermia tratment increasingly becomes part of standard management in these patients.
The observational nature of this study introduces potential bias regarding the decision to perform imaging and the timing of the scan. Ideally, imaging would be obtained at admission and at 3 days. Many patients died because of withdrawal of care, a common problem in these studies, resulting in a self-fulfilling prophecy of poor outcome in patients who may have otherwise recovered. 2 Clinicians in this study were not blinded to the CT or any other data, and thus abnormal CTs might have swayed the treating team. However, the treating team did not do a quantitative evaluation of HUs, and thus any patient management decisions based on imaging findings would likely have been based purely on drastic gross changes, which were not common in our population. Prospective studies are clearly needed with prespecified imaging and neurological examination times, as well as sufficient time to allow for recovery in patients for whom the outcome is in question.
